Background: Different tissues express genes with particular codon usage and anticodon 12 tRNA repertoires. However, the codon-anticodon co-adaptation in humans is not completely 13 understood, as well as its effect on tissue-specific protein levels. 14
KEYWORDS 26 tRNA, translation, The Cancer Genome Atlas, tissue, regulation, miRNA, codon usage 27 BACKGROUND 28 In the light of the genetic code, multiple 3-letter combinations of nucleotides in the mRNA 29 can give rise to the same amino acid, which are known as synonymous codons. However, 30 despite the homology at the protein level, these different codons are recognized distinctly by 31 the transcriptional and translational machineries (1, 2) , and ultimately cause changes at 32 multiple levels of gene expression. Therefore, the non-uniform abundance of synonymous 33 codons across different tissues and among distinct functional gene sets has been proposed 34 as an adaptive mechanism of gene expression regulation (3), particularly linked to the 35 proliferative state (4). Nevertheless, in human, it is still under debate whether the efficiency 36 of gene expression is the main selective pressure driving the evolution of genomic codon 37 usage (5). 38
The 61 amino-acid-coding codons need to be recognized by 46 different tRNA isoacceptors 39 distributed across 428 Pol-III-transcribed tRNA genes (6), thus requiring wobble interactions 40 (non-Watson-Crick base pairing). This complexity of the tRNA repertoire is further enhanced 41 by an average of 11-13 base modifications per tRNA and all possible combinations thereof 42 (7) . The underlying mechanisms regulating tRNA gene expression and modification are far 43 from resolved (8, 9) . However, it has been established that different conditions and tissues 44 showcase distinct tRNA abundances (4,10) and codon usages (3, 11) . 45
In order to understand such changes in codon-anticodon co-adaptation, orthogonal datasets 46 of gene expression including tRNA quantification are required, which needs to overcome the 47 challenges of strong secondary structures and abundant chemical modifications. Recent 48 technological developments have paved the way for sensitive high-throughput tRNA 49 sequencing across tissues and conditions (12, 13) . Aside from these methods and despite 50 the lower coverage, tRNA reads can also be detected from generic small RNA-seq datasets 51 accurate mapping of tRNA reads (16) in order to quantify all different isoacceptor species 78 ( Figure 1A , see Methods). To validate the accuracy of these small RNA-seq quantifications, 79 we retrieve three datasets of well-established tRNA sequencing methods (Hydro-tRNAseq 80 and demethylase-tRNA-seq) applied to the same cell type (12, 13, 21) , which autocorrelate in 81 the range of 0.72-0.79 among themselves (Table S1 ). In comparison, our four HEK293 small 82 RNA-seq quantifications show an average Spearman correlation against these three 83 conventional datasets of 0.68. Compared to the anticodon Spearman correlation of 0.61 as 84 published by Zhang et al. (19) , our tRNA-specific mapping pipeline performs better than the 85 previously published protocol, since all our correlations lie over that value. 86
Further than correlating small RNA-seq data with conventional tRNA-seq datasets, we 87 analyze whether small RNA-seq quantifications are informative enough to distinguish 88 between different human cell lines covering multiple tissue types. We therefore apply both 89 small RNA-seq and Hydro-tRNAseq to HEK293 (kidney), HCT116 (colon), HeLa (cervix), 90 MDA-MB-231 (breast), and BJ fibroblasts. However, given the high variability between 91 replicates of MDA-MB-231 Hydro-tRNAseq quantifications, this cell line was excluded from 92 further analyses (Table S2 ). First, the correlations between the two methods of identical 93 samples and computational mapping pipeline range between 0.93 and 0.96 for all cell lines. 94 tRNA quantifications from both protocols are compared and significantly higher Spearman 95 correlations are obtained within matching samples versus mismatching cell lines ( Figure 1B) . 96
In consequence, we demonstrate that small RNA-seq quantifications of sample-specific 97 tRNA profiles show a good agreement with Hydro-tRNAseq. 98
We also detect tRNA base modifications in both protocols by nucleotide variant calling, as 99 described in Hoffmann et al. (16) . In all cases, considering the modifications that are 100 detected in all three replicates, Hydro-tRNAseq datasets identify a larger number of 101 modifications than small RNA-seq, as expected by the more uniform and deeper coverage of 102 this method (Table S2 ). Furthermore, we detect a significant enrichment of the Hydro-103 tRNAseq modifications in the small RNA-seq data (p < 1e-16, Fisher test), indicating that the 104 latter contains also information on tRNA modifications ( Figure 1C ). 105
Taken together, these observations demonstrate the applicability of small RNA-seq data for 106 the quantification tRNAs and their modifications. We therefore apply the same computational 107 pipeline to all healthy and primary tumor small RNA-seq samples from 23 cancer types of 108
The Cancer Genome Atlas (TCGA), which consists of 8,605 samples distributed among 17 109 different human tissues ( Figure 1D , number of samples and their abbreviations in Table S3 ). 110 
Proliferation is the major driver of tissue-specificity in tRNAs 119
To determine the tissue-specificity of tRNAs in physiological conditions, the tRNA levels of 120 all 675 healthy samples in TCGA tissues are analyzed. The isoacceptor abundances show 121 a significant tissue-specificity for all 46 annotated anticodons (q<0.05, FDR-corrected 122
Kruskal-Wallis test grouped by cancer types). Such differences between tissues are also 123 observed by hierarchical clustering of the median expression between all groups ( Figure  124 2A). Furthermore, healthy samples from cancer types originating from the same tissue tend 125 to cluster together: READ and COAD from the gut; KIRC, KIRP and KICH from the kidney; 126 LUAD and LUSC from the lung; UCEC and CESC from the uterus; LIHC and CHOL from the 127 liver (refer to Table S3 for full cancer names). On the other hand, in terms of anticodon 128 abundances, three main subgroups of tRNAs with low, medium and high expression can be 129 distinguished across all cancer types ( Figure 2A ). 130
Regarding codon usage, a measure of tRNA abundance taking into account the relative 131 contribution of each tRNA anticodon among the set of codons of a certain amino acid is the 132 Relative Anticodon Abundance. From this perspective, a principal component analysis (PCA) 133 of the healthy control samples in TCGA also shows clear differences between tissues 134 ( Figure 2B ). Moreover, our first component, which explains 18.5% of the variance, correlates 135 positively with the proliferation marker Ki67 (R spearman = 0.45) (25). To further interrogate the 136 biological functions related to the variability of anticodon abundances between samples, we 137 compute the correlation of the whole mRNA-seq transcriptome against the first PCA 138 component, and analyze it by Gene Set Enrichment Analysis (GSEA). As a result, the top 139 correlating genes are enriched in proliferation and immune cell activation, while the lowest 140 correlations belong to genes related with oxidative metabolism and respiration ( Figure 2C , 141 Table S4 ). This confirms, as has been previously suggested (4), that there is a proliferative 142 tRNA expression program. 143
Overall, we observe patterns of tissue-specific tRNA expression in TCGA healthy samples. 144 Furthermore, our analysis identifies the proliferative state of tissues as the major biological 145 function driving the variability on tRNA abundances. 146 Given that different tissues express distinct tRNA repertoires, we wondered whether they 156 could have an effect in protein translation. In this context, and based on previous studies 157 underscoring the global control role of codon usage as a competition for a limited tRNA pool 158 (26-28), we define the Relative Translation Efficiency (RTE) as the balance between the 159 supply (i.e. the anticodon tRNA abundances) and demand (i.e. the weighted codon usage 160 based on the mRNA levels) for each of the 60 codons (excluding methionine and Stop 161 codons). Furthermore, we normalize both the codon and anticodon abundances within each 162 amino acid family (i.e. relative to the most abundant synonymous codon/anticodon), in order 163 to remove the effect of amino acid biases and get a cleaner measure of codon optimality 164 (29). 165
To validate the suitability of RTE in determining the translational efficiency, we correlate the 166 RTE value of all proteins against the available proteomics data of paired TCGA samples 167 (30,31), which includes breast and colorectal tissues (tumor only, as no healthy samples are 168 available). Although the correlation is poor (but significant), both the protein abundances and 169 the protein-to-mRNA ratios correlate significantly better with RTE than with the classical 170 tRNA Adaptation Index [tAI] (32,33) or with a relative tAI with normalized weights within each 171 amino acid family, which do not consider the mRNA codon demand ( Figure 3A) . 172 Furthermore, the correlation of RTE with protein-to-mRNA ratio is slightly but significantly 173 higher than with protein levels alone, which indicates that the first is a better proxy for the 174 process of translation. 175
Next, we calculate the RTE for the 620 healthy samples for which both tRNA abundances 176 and mRNA levels are available. When analyzing the tissue medians of RTE weights per 177 each codon (RTEw), we observe that most codons are optimally balanced (RTEw =1), while 178 12.4% and 23.6% of codons are favored (RTEw >2) and disfavored (RTEw <0.5) 179 respectively. The tissue clustering again shows that healthy samples of cancer types from 180 the same tissue have similar RTEw profiles, which separates two major clusters of mostly 181 high-Ki67 and low-Ki67 tissues ( Figure S1 ). 182
In order to identify the codons contributing most to the differences between tissues, we 183 compute a bidimensional PCA across all samples and RTEw ( Figure 3B ). Both the first and 184 second components significantly correlate with the proliferation marker Ki67 (0.4 and 0.35; 185 see Figure 2B ). In agreement with the proliferation-and differentiation-related codons of 186 Gingold et al. (4) , such proliferative pattern is similarly reproduced by the codons 187 contributing to the first PCA component, which has the strongest association to proliferation 188 ( Figure 3B ). Further, similarly to the tRNA abundances ( Figure 2B ), a GSEA of correlating 189 genes with the first component highlights the link with proliferation-related terms (Table S5) . 190
On the other hand, the first component also clearly separates codons based on the GC 191 content of the third codon base, which has recently been associated with differentiation (high 192 in nnC/G codons) versus self-renewal functions (high in nnA/T) (34), as well as with 193 proliferative transcriptomes (35). 194
The previous analyses support the idea of proliferation-related tRNAs driving changes in 195 translational efficiencies. In that case, we expect that the two most extreme tissues in terms 196 of proliferation (brain and gut, excluding thymus for its low number of samples) differ in the 197 optimization of proliferation-related proteins. As such, we compute the average RTEw for 198 these two tissues, analyze the subsequent RTE score for each protein, and perform a GSEA 199 of the differential RTE per protein. Consistent with our hypothesis, the results indicate that 200 gut-optimized proteins are enriched in translation, DNA replication and protein localization, 201 whereas brain-optimized proteins are related to phospholipid production and neural function 202 ( Figure 3C , Table S6 ). Taken together, this result confirms that the tRNA-dependent 203 translational efficiency is optimized for the translation of tissue-specific genes, particularly in 204 function of the proliferation state. 205 to Supplementary Table 3 for full cancer type names. 219
Aberrant translational efficiencies drive tumor progression 220
Given that proliferation is a major determinant of translational efficiency in healthy tissues, its 221 importance could be extrapolated to pathological conditions such as cancer. In fact, aberrant 222 expression of tRNAs and codon usage have been broadly related with tumorigenesis and 223 cancer progression (19,20,36,37). We therefore investigate 22 cancer types from TCGA in 224 order to determine which codons are translationally compromised in disease. 225
Similar to the analysis performed on the healthy tissues, we quantify all tRNA abundances of 226 TCGA primary tumor samples ( Figure S2 ) and determine their corresponding translational 227 efficiencies using the RTE metric. By analyzing the differential RTEw between normal and 228 tumor samples, we observe many significant differences in all 60 codons across the 22 229 cancer types ( Figure 4A ). Among the most consistent changes, the ProCCA codon is 230 significantly more favored in tumors for 8 out of 10 cancer types, while the ProCCG is 231 disfavored in 14 out of 16 cancers ( Figure 4B ). In the case of glycine, translation appears 232 more efficient for GlyGGT in healthy samples (13/13), whereas tumor mostly favors GlyGGC 233 (9/12) and GlyGGG (7/9). 234
In terms of patient survival, we divide the TCGA patients in two groups based on their low or 235 high tumor RTEw and analyze their survival probability ( Figure 4C , Table S7) (Table S8 ). As the RTEw of the ProCCA is specifically disturbed in 249 cancer, we also interrogate how this codon is distributed along the genome. We therefore 250 perform a GSEA on the relative codon usage of ProCCA, which shows that DNA replication 251 and cell cycle functions lie among the most CCA-enriched genes, while morphogenesis and 252 differentiation terms are CCA-depleted (Table S9 ). Together with the low-proliferative state 253 of kidney ( Figure 2B ), the over-efficiency of a proliferation-related codon in this tissue can 254 thus perturb its cellular RTE. 255
Overall, we detect differences at the level of RTEw between tumor and healthy tissues, 256 which show a functional relevance to the disease state. Therefore, while the differential 257 expression of tRNAs in TCGA had been already discussed elsewhere (19,20), we could here 258 elucidate their oncogenic effect in translational efficiency. In particular, ProCCA appears as 259 an interesting codon candidate in favoring tumor progression, which we had also detected in 260 healthy tissues to be associated with proliferation ( Figure 3B , Table S5 ). 261 In order to make the gene-based data comparable with the measured isoacceptor-based 279 tRNA expression, we average methylation and CNA levels over all genes within the same 280 isoacceptor family, at the cost of losing resolution. For each isoacceptor and each cancer 281 type, we finally fit a Multiple Linear Regression to determine how are promoter methylation 282 and CNA affecting tRNA expression ( Figure 5A , Table S10 ). Among all models, the 283 significant coefficients for methylation and CNA are significantly negative and positive, 284 respectively. Despite the limited explained variance of the models (average R 2 =0.023), such 285 results indicate that promoter methylation contributes to inhibition of tRNA gene expression, 286 while an increase in the gene copy number enhances tRNA expression. 287
Given the association of the codon ProCCA with cancer prognosis (Figure 4C ), we explore 288 the expression pattern of tRNAPro in TCGA. In particular, tRNAPro AGG , which recognizes the 289 codon ProCCA, is overexpressed in 8 out of 9 cancer types ( Figure S2A ). To get a more 290 accurate picture of the tRNA gene methylation levels, we also analyze recently published 291 bisulfite sequencing data (39), which, for 47 samples among nine cancer types, improved 292 the coverage of tRNA genes up to an average of 81%. In total, tRNAPro AGG genes stand 293 among the most duplicated and least methylated proline isoacceptors in cancer ( Figure S3A -294 B), in particular at the chr6.tRNA12 and chr16.tRNA12 genes ( Figure 5B ). Furthermore, 295 tRNAPro AGG gene duplications occur most frequently in kidney cancers ( Figure S3C ). On the 296 other hand, although the other CCA-decoding tRNAPro TGG is not differentially expressed in 297 cancer ( Figure S2 ), its genes are as similarly methylated and duplicated as tRNAPro AGG 298 ( Figure 5B, Figure S3 ). 299
In short, promoter methylation and CNA appear as two possible regulatory mechanisms of 300 tRNA expression in cancer, which suggests that similar mechanisms that control the Pol-II-301 mediated RNAs might also regulate the expression of Pol-III non-coding transcriptome, such 302 as tRNA genes. However, more accurate and high-throughput data on the methylation and 303 CNA of the non-coding genome together with gene-based tRNA quantifications are needed 304 to make stronger associations. 305 
DISCUSSION

316
In this study, we use a systems biology approach to interrogate the multi-omics TCGA 317 dataset under the perspective of translational efficiencies. We therefore first validate the 318 suitability of small RNA-seq data in reproducing conventional tRNA-seq quantifications 319 based on a gold standard set of five tissue-wide human cell lines. In fact, knowing that small 320 RNA-seq datasets have a limited tRNA coverage and tend to be biased towards tRNA 321 fragments and unmodified tRNAs (18, 40) , we extend and apply a computational pipeline for 322 accurate mapping of tRNA reads (16). As a result, we obtain reproducible and informative 323 quantifications of all isoacceptors in our gold standard cell lines as well as in thousands of 324 samples across 23 cancer types of TCGA, exceeding the quality of similarly published data 325 (19, 20) . 326
From these quantifications, we then elucidate their effect on the translational efficiency by 327 defining the RTE, for Relative Translation Efficiency, which is a balance between the tRNA 328 supply and the codon demand. Although a more accurate RTE would have determined the 329 supply and demand based on the aminoacylated portion of tRNAs (41) and the ribosome-330 bound mRNAs (42) respectively, we approximate such measures by our tRNA 331 quantifications and the publicly-available mRNA-seq data of TCGA. In agreement with 332 current studies showing that a dynamic codon usage need to compete for a limited tRNA 333 pool (28,29), we demonstrate that RTE is better measure of codon optimality than previously 334 published metrics such as the tAI (32,33). However, far from explaining the translation 335 process, the still low but significant correlations of protein-RTE in human, in contrast to 336 unicellular organisms, suggest that protein expression is also dependent on other layers of 337 regulation, such as transcriptional and post-transcriptional machineries, translation initiation, 338 epigenetic modifications of DNA and RNAs, or protein degradation mechanisms (43). 339
On the level of translational efficiency, in agreement with previous studies (4,36), we detect 340 that the proliferative state is the major determinant of RTE differences both across healthy 341 tissues and in cancer. Moreover, in contrast to recent work challenging the tissue-specificity 342 of codon-anticodon co-adaptation in human (29,43), our data here support the idea that 343 tissue-specific RTEw have functional implications on the tissue phenotype (e.g. in 344 determining neural differentiation in brain, or inducing abnormal proliferation in cancer). In an effort to elucidate the mechanisms regulating the expression of tRNAs, we observe 358 that the tRNA gene copy number and their DNA methylation state have a positive and 359 inhibitory effect on tRNA expression, respectively. In this context, DNA methylation has 360 previously been linked to the silencing of type II genes (such as tRNAs) of the Pol-III 361 transcriptome (44). Here we specifically propose a role for DNA methylation in regulating the 362 overexpression of tRNAPro AGG in cancer. In terms of the copy number alterations, it is not 363 surprising to detect tRNA gene duplications in tumors, but the functional role in disease of 364 different isodecoder genes that share the same anticodon is still a matter of debate (45). 365
With the advent of more accurate and high-throughput multi-omics datasets, our knowledge 366 on the underlying mechanisms controlling tRNA expression, degradation, and the effect of 367 their modifications will be further expanded (8, 9) . Recent studies in TCGA have actually 368 observed an upregulation of tRNA-modifying enzymes, as well as proposed a link of tRNA-369 derived fragments (tRF) to proliferation (19, 46) . 370 CONCLUSIONS 371 This is the first high-throughput study of codon-anticodon translational efficiency over 372 thousands of samples comprising multiple tissues and disease. We therefore demonstrate a 373 functional role for the proliferation-driven tRNA expression differences in determining a 374 tissue-specific phenotype, both in physiological and pathological conditions. In the future, we 375 expect to validate the effect of such differential translational efficiency by integrating 376 perturbation based data and including additional gene expression regulatory layers such as 377 tRNA modifications. 378
METHODS
379
Cell lines 380
The cell lines included in this study are HeLa, HEK293, HCT116, MDA-MB-231 and 381 fibroblast BJ/hTERT. Cells were maintained at 37 °C in a humidified atmosphere at 5% CO2 382 in DMEM 4.5g/L Glucose with UltraGlutamine media supplemented with 10% of FBS and 1% 383 penicillin/streptomycin. 384
RNA extraction 385
Cells were grown in 60mm dishes for 48h. Total RNA from HeLa, HEK293, HCT116, MDA-386 MB-231 and fibroblast BJ/hTERT was extracted using the miRNeasy Mini kit. Independent 387 replicates where grown and RNA was extracted on different days. 20 µg of total RNA was 388 treated following either the protocol of Hydro-tRNAseq (12) or generic small RNA-seq. 389
Hydro-tRNA sequencing 390
Total RNA was resolved on 15% Novex TBE urea gels and size-selected for 60-100 nt 391 fragments. The recovered material was then alkaline hydrolyzed (10mM sodium carbonate 392 and 10mM sodium bicarbonate) for 10 minutes at 60ºC. The resulting RNA was de-393 From all five cell lines, the isoacceptor abundances of MDA-MB-231 yielded a median of 3-5 401 times higher standard deviation than the other Hydro-tRNAseq quantifications (Table S2) Trimmed FASTQ files were then mapped using a specific pipeline for tRNAs ( Figure 1A ) 418 (16). Summarizing, an artificial genome is first generated by masking all annotated tRNA 419 genes and adding pre-tRNAs (i.e. tRNA genes with 3' and 5' genomic flanking regions) as 420 extra chromosomes. Upon mapping to this artificial genome with Segemehl [v0.3.1] (48), 421 reads that map to the tRNA-masked chromosomes or to the tRNA flanking regions are 422 filtered out in order to remove non-tRNA reads and unmature-tRNA reads respectively. 423
After this first mapping step, a second library is generated by adding 3' CCA tails and 424 removing introns from tRNA genes. All 100% identical sequences of this so-called mature 425 tRNAs are clustered to avoid redundancy. Next, the subset of filtered reads from the first 426 mapping is aligned against the clustered mature tRNAs using Segemehl [v0.3.1] (48). 427
Mapped reads are then realigned with GATK IndelRealigner [v3.8] (49) to reduce the 428 number of mismatching bases across all reads. 429
For quantification, isoacceptors were quantified as reads per million (RPM). In order to 430 increase the coverage for anticodon-level quantification, we consider all reads that map 431 unambiguously to a certain isoacceptor, even though they ambiguously map to different 432 isodecoders (i.e. tRNA genes that differ in their sequence but share the same anticodon). 433
Ambiguous reads mapping to genes of different isoacceptors were discarded. 434
Regarding modification site calling, we only considered gene-level uniquely mapped reads, 435 as described to be optimal in Hoffmann et al. (16) . As in their pipeline, in order to distinguish 436 mapping or sequencing errors from true misincorporation sites, we use GATK 437 UnifiedGenotyper [v3.8] (49). 438
Relative Codon Usage (RCU) and Relative Anticodon Abundance (RAA) 439
The RCU/RAA is defined as the contribution of a certain codon/anticodon to the amino acid it 440 belongs to. The RCU of all synonymous codons and the RAA of all anticodons recognizing 441 synonymous codons therefore sum up to 1. 442 
Relative Translation Efficiency (RTE) 462
The RTE aims to consider not only tRNA abundances, but also the codon usage demand. In 463 doing so, it constitutes a global measure of translation control, since the efficiency of a 464 certain codon depends both on its complementary anticodon abundance as well as the 465 demand for such anticodon by other transcripts. This global control has been indeed 466 established to play an important role in defining optimal translation programs (28). 467
The definition of the RTE is based on similar previously published metrics (26,27), which 468 consists of a ratio between the anticodon supply and demand. On the one hand, the 469 anticodon supply is defined as the relative tAI weights 
Gene Set Enrichment Analysis (GSEA) 482
We analyzed the enrichment of gene sets of the GO Biological Process Ontology using the 483 GSEA algorithm (50). The score used to generate the ranked list input is specified in the text 484 for each analysis. extracted the corresponding value for the genomic coordinates containing the tRNA genes. 501 Whenever the tRNA genes was located between two segments, the weighted average in 502 function of the gene overlap with each segment was computed. 503
Bisulfite sequencing methylation 504
As 1500TSS methylation of tRNA genes lead to an average coverage of only 37% genes, 505 we also analyzed the recently published bisulfite sequencing data of 47 samples across nine 506 cancer types (Table S3 ) (39). After retrieving the datasets from the GDC legacy archive, 507
given the higher resolution of bisulfite sequencing data, we restricted the computation of the 508 average promoter methylation of tRNA genes to the GRCh37/hg19 genomic coordinates 509 containing the tRNA genes, since the promoter region of Pol-III-genes is intragenic. 510
Multiple Linear Regression (MLR) 511
We fitted a Multiple Linear Regression (MLR) between the square-root-normalized tRNA 512 expression (dependent variable) and the promoter methylation and gene copy number 513 (independent variables). To make all three layers of information comparable, we considered 514 only samples for which all data was available and performed the regression at the 515 isoacceptor level, thus averaging the methylation and CNA data over all tRNA genes that 516 shared the same anticodon. 517
We fitted the model parameters for all 64 isoacceptors and 22 cancer types, leading to 518 22x64=1408 MLRs, among which only significant coefficients (FDR-corrected t-statistic p-519 value < 0.05) were considered in downstream analyses. 520
Statistical Analysis 521
For hypothesis testing, an unpaired two-tailed Wilcoxon rank-sum test was performed, 522 unless stated otherwise. All details of the statistical analyses can be found in the Results 523 section. We used a significance value of 0.05. In differential expression analyses, a False 524 Discovery Rate correction was used to account for multiple testing. 525
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AVAILABILITY OF DATA AND MATERIALS 564
HEK293 Small RNA-seq datasets 565
The four HEK293 datasets were downloaded from the NCBI Sequence Read Archive (SRA): 566 SRR1304304, ERR705692, ERR705691, SRR2060090. 567
The Cancer Genome Atlas 568
Raw small RNA-sequencing data in BAM format were retrieved from the GDC legacy archive 569 after obtaining the necessary permissions from dbGaP, comprising all healthy samples (NT, 570 solid tissue normal) and their primary tumor (PT) counterparts, which consists of 23 cancer 571 types (BRCA, PRAD, KICH, KIRP, KIRC, LUAD, LUSC, HNSC, UCEC, CESC, LIHC, CHOL, 572 THCA, COAD, READ, ESCA, STAD, BLCA, PAAD, THYM, SKCM, PCPG, GBM). For 573 samples for which more than one BAM was available, all files were downloaded. BAM files 574 were converted to FASTQ using SAMtools [v1.3.1] (51). We retrieved publicly available and 575 pre-processed mRNA-seq gene expression, 450k DNA methylation, and SNP6 segmented 576 copy number alteration (CNA) from firebrowse. As for proteomics, preprocessed protein 577 assembly data and protein relative abundance were obtained from CPTAC for TCGA 578 samples including BRCA, COAD and READ. 579
Coding sequences 580
The coding sequences of Homo sapiens from RefSeq were downloaded from the 581 Codon/Codon Pair Usage Tables (CoCoPUTs) project 
